Lonza Pharma & Biotech has launched SimpliFiH Services, integrating its capabilities in addressing bioavailability challenges with drug substance, solid-state characterization and drug product for first-in-human studies.   Lonza’s new service package has been specifically designed for innovator companies that have solubility-challenged molecules and require drug substance and drug product services for early-stage development and first-in-human studies. Streamlined service agreement templat...